Terms: = Endocrine gland cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Clinical Outcome
5 results:
1. Genetic and epigenetic characterization of posterior pituitary tumors.
Schmid S; Solomon DA; Perez E; Thieme A; Kleinschmidt-DeMasters BK; Giannini C; Reinhardt A; Asa SL; Mete O; Stichel D; Siewert C; Dittmayer C; Hasselblatt M; Paulus W; Nagel C; Harter PN; Schittenhelm J; Honegger J; Rushing E; Coras R; Pfister SM; Buslei R; Koch A; Perry A; Jones DTW; von Deimling A; Capper D; Lopes MB
Acta Neuropathol; 2021 Dec; 142(6):1025-1043. PubMed ID: 34661724
[TBL] [Abstract] [Full Text] [Related]
2. Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients.
Yamazaki Y; Gao X; Pecori A; Nakamura Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Satoh F; Sasano H
Front Endocrinol (Lausanne); 2020; 11():587769. PubMed ID: 33193100
[TBL] [Abstract] [Full Text] [Related]
3. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.
Zheng S; Cherniack AD; Dewal N; Moffitt RA; Danilova L; Murray BA; Lerario AM; Else T; Knijnenburg TA; Ciriello G; Kim S; Assie G; Morozova O; Akbani R; Shih J; Hoadley KA; Choueiri TK; Waldmann J; Mete O; Robertson AG; Wu HT; Raphael BJ; Shao L; Meyerson M; Demeure MJ; Beuschlein F; Gill AJ; Sidhu SB; Almeida MQ; Fragoso MCBV; Cope LM; Kebebew E; Habra MA; Whitsett TG; Bussey KJ; Rainey WE; Asa SL; Bertherat J; Fassnacht M; Wheeler DA; ; Hammer GD; Giordano TJ; Verhaak RGW
Cancer Cell; 2016 May; 29(5):723-736. PubMed ID: 27165744
[TBL] [Abstract] [Full Text] [Related]
5. Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
Uehara Y; Oda K; Ikeda Y; Koso T; Tsuji S; Yamamoto S; Asada K; Sone K; Kurikawa R; Makii C; Hagiwara O; Tanikawa M; Maeda D; Hasegawa K; Nakagawa S; Wada-Hiraike O; Kawana K; Fukayama M; Fujiwara K; Yano T; Osuga Y; Fujii T; Aburatani H
PLoS One; 2015; 10(6):e0128066. PubMed ID: 26043110
[TBL] [Abstract] [Full Text] [Related]
